Related Experiment Video

Updated: Jun 5, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Impact of new clinical trials on recent guidelines on hypertension management

Giuseppe Mancia1, Guido Grassi

  • 1Clinica Medica, Ospedale San Gerardo dei Tintori (Monza), Università Milano-Bicocca, Milan, Italy. giuseppe.mancia@unimib.it

Annals of Medicine
|January 25, 2011
PubMed

Insights

Recent clinical trials have clarified hypertension management, addressing drug benefits, blood pressure targets, and combinations. These findings update European hypertension guidelines, impacting cardiovascular risk reduction strategies.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • European hypertension guidelines were established in 2007.
  • Significant clinical trials have since investigated key aspects of hypertension management.
  • Unresolved questions concerned cardiovascular risk, nephroprotection, blood pressure targets, drug combinations, and elderly patient treatment.

Purpose of the Study:

  • To review the 2007 European hypertension guidelines.
  • To highlight new concepts and recommendations from recent intervention trials.
  • To integrate findings on blood pressure-lowering interventions and cardiovascular events.

Main Methods:

  • Analysis of major intervention clinical trials completed after 2007.
  • Review of the 2009 update document for European hypertension guidelines.
  • Synthesis of evidence on antihypertensive drug efficacy and safety.

Main Results:

  • Recent trials provided clear answers on nephroprotective effects of antihypertensives.
  • Evidence clarified optimal blood pressure targets for various hypertensive patient groups.
  • The benefits of specific drug combinations and use in the elderly were elucidated.

Conclusions:

  • The 2009 European guideline update incorporates crucial findings from recent hypertension trials.
  • New recommendations focus on optimizing cardiovascular risk reduction through targeted antihypertensive therapy.
  • Intervention trial results have refined understanding of hypertension management strategies.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...